The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseases Cureverse receives undisclosed upfront payments and is eligible for future milestone-dependent payments and royalties, while retaining rights to commercialize CV-01 in the Republic of […]

Collaboration to include the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-I&T and 64Cu-PSMA-I&T Builds on long-standing relationship between the two companies In Japan around 90,000 new cases of prostate cancer are diagnosed each year PARIS, Oct. 01, 2024 (GLOBE NEWSWIRE) — Curium, a world leader in nuclear medicine, announced today that it has entered […]

Miami, July 01, 2024 (GLOBE NEWSWIRE) — Miami, FL – July 1st , 2024. Aleph Group, the global leader in connecting leading global digital media platforms with advertisers and consumers in primarily emerging markets, today announced the completion of its acquisition of Entravision Global Partners (“EGP”), the digital commercial partnership business unit of Entravision Communications Corporation. This  […]

Miami, July 01, 2024 (GLOBE NEWSWIRE) — Miami, FL – July 1st , 2024. Aleph Group, the global leader in connecting leading global digital media platforms with advertisers and consumers in primarily emerging markets, today announced the completion of its acquisition of Entravision Global Partners (“EGP”), the digital commercial partnership business unit of Entravision Communications Corporation. This  […]

Nyxoah Announces 2024 Strategic Priorities Mont-Saint-Guibert, Belgium – January 17, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced, in anticipation of upcoming investor meetings, its strategic […]